Notch signals in the endothelium and cancer "stem-like" cells: Opportunities for cancer therapy

Vascular Cell

Volumn 4, Issue , 2012, Pages

  Gu, Jian Wei ^a   Rizzo, Paola ^b   Pannuti, Antonio ^a   Golde, Todd ^c   Osborne, Barbara ^d   Miele, Lucio ^a,e  

^a UNIVERSITY OF MISSISSIPPI   (United States)

^b IRCCS   (Italy)

^c UNIVERSITY OF FLORIDA   (United States)

^d UNIVERSITY OF MASSACHUSETTS   (United States)

^e UNIVERSITY OF MISSISSIPPI MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE 3; CHEMOKINE RECEPTOR CXCR4; DLL1 PROTEIN; DLL4 PROTEIN; GAMMA SECRETASE INHIBITOR; JAGGED1; NOTCH RECEPTOR; PROTEIN; SIMVASTATIN; STROMAL CELL DERIVED FACTOR 1; SUNITINIB; UNCLASSIFIED DRUG; VASCULOTROPIN; VASCULOTROPIN A; VASCULOTROPIN C; VASCULOTROPIN INHIBITOR; VASCULOTROPIN RECEPTOR 3;

ANGIOGENESIS; ANTIANGIOGENIC THERAPY; BREAST CANCER; CADASIL; CANCER STEM CELL; CANCER THERAPY; CELL FATE; CELL FUNCTION; CELL GROWTH; CELL SURVIVAL; ENDOTHELIAL PROGENITOR CELL; ENDOTHELIUM CELL; HEMATOPOIETIC STEM CELL; HOMEOSTASIS; HUMAN; ISCHEMIA; LEUKEMIA; LUNG CANCER; NONHUMAN; POSTNATAL DEVELOPMENT; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION; TUMOR MICROENVIRONMENT; WILD TYPE;

EID: 84867903740     PISSN: None     EISSN: 2045824X     Source Type: Journal    
DOI: 10.1186/2045-824X-4-7     Document Type: Review

References (101)

1. Effects of disturbed flow on vascular endothelium: pathophysiological basis and clinical perspectives. Chiu JJ, Chien S, Physiol Rev 2011 91 327 387
2. Instructive role of the vascular niche in promoting tumour growth and tissue repair by angiocrine factors. Butler JM, Kobayashi H, Rafii S, Nat Rev Cancer 2010 10 138 146
3. Signal transduction induced in endothelial cells by growth factor receptors involved in angiogenesis. Hofer E, Schweighofer B, Thromb Haemost 2007 97 355 363 (Pubitemid 46437796)
4. Novel insights into the differential functions of Notch ligands in vascular formation. Kume T, J Angiogenes Res 2009 1 8
5. Targeting Notch to target cancer stem cells. Pannuti A, Foreman K, Rizzo P, Osipo C, Golde T, Osborne B, et al. Clin Cancer Res 2010 16 3141 3152
6. Notch signaling: cell fate control and signal integration in development. Artavanis-Tsakonas S, Rand MD, Lake RJ, Science 1999 284 770 776 (Pubitemid 29291335)
7. The canonical Notch signaling pathway: unfolding the activation mechanism. Kopan R, Ilagan MX, Cell 2009 137 216 233
8. Notch signaling. Miele L, Clin Cancer Res 2006 12 1074 1079 (Pubitemid 43342494)
9. Notch signaling in blood vessels: who is talking to whom about what? Hofmann JJ, Iruela-Arispe ML, Circ Res 2007 100 1556 1568 (Pubitemid 46897259)
10. Vascular expression of Notch pathway receptors and ligands is restricted to arterial vessels. Villa N, Walker L, Lindsell CE, Gasson J, Iruela-Arispe ML, Weinmaster G, Mech Dev 2001 108 161 164 (Pubitemid 32918185)
11. Notch signalling in ischaemia-induced angiogenesis. Al Haj ZA, Madeddu P, Biochem Soc Trans 2009 37 1221 1227
12. Notch signaling is essential for vascular morphogenesis in mice. Krebs LT, Xue Y, Norton CR, Shutter JR, Maguire M, Sundberg JP, et al. Genes Dev 2000 14 1343 1352 (Pubitemid 30397078)
13. Endothelial expression of the Notch ligand Jagged1 is required for vascular smooth muscle development. High FA, Lu MM, Pear WS, Loomes KM, Kaestner KH, Epstein JA, Proc Natl Acad Sci USA 2008 105 1955 1959 (Pubitemid 351439446)
14. Notch3 is required for arterial identity and maturation of vascular smooth muscle cells. Domenga V, Fardoux P, Lacombe P, Monet M, Maciazek J, Krebs LT, et al. Genes Dev 2004 18 2730 2735 (Pubitemid 39507766)
15. Embryonic lethality and vascular defects in mice lacking the Notch ligand Jagged1. Xue Y, Gao X, Lindsell CE, Norton CR, Chang B, Hicks C, et al. Hum Mol Genet 1999 8 723 730 (Pubitemid 29189039)
16. Notch3 mutations in CADASIL, a hereditary adult-onset condition causing stroke and dementia. Joutel A, Corpechot C, Ducros A, Vahedi K, Chabriat H, Mouton P, et al. Nature 1996 383 707 710 (Pubitemid 26360644)
17. Notch signaling in vascular development. Iso T, Hamamori Y, Kedes L, Arterioscler Thromb Vasc Biol 2003 23 543 553 (Pubitemid 36438065)
18. Vascular endothelial growth factor: basic science and clinical progress. Ferrara N, Endocr Rev 2004 25 581 611 (Pubitemid 39099316)
19. VEGF receptor signalling-in control of vascular function. Olsson AK, Dimberg A, Kreuger J, Claesson-Welsh L, Nat Rev Mol Cell Biol 2006 7 359 371
20. VEGF guides angiogenic sprouting utilizing endothelial tip cell filopodia. Gerhardt H, Golding M, Fruttiger M, Ruhrberg C, Lundkvist A, Abramsson A, et al. J Cell Biol 2003 161 1163 1177 (Pubitemid 36870177)
21. VEGF and Delta-Notch: interacting signalling pathways in tumour angiogenesis. Thurston G, Kitajewski J, Br J Cancer 2008 99 1204 1209
22. Regulation of Notch1 and Dll4 by vascular endothelial growth factor in arterial endothelial cells: implications for modulating arteriogenesis and angiogenesis. Liu ZJ, Shirakawa T, Li Y, Soma A, Oka M, Dotto GP, et al. Mol Cell Biol 2003 23 14 25 (Pubitemid 36008497)
23. Regulation of vascular morphogenesis by Notch signaling. Roca C, Adams RH, Genes Dev 2007 21 2511 2524 (Pubitemid 47607663)
24. Notch regulates the angiogenic response via induction of VEGFR-1. Funahashi Y, Shawber CJ, Vorontchikhina M, Sharma A, Outtz HH, Kitajewski J, J Angiogenes Res 2010 2 3
25. Notch modulates VEGF action in endothelial cells by inducing Matrix Metalloprotease activity. Funahashi Y, Shawber CJ, Sharma A, Kanamaru E, Choi YK, Kitajewski J, Vasc Cell 2011 3 2
26. Regulation of multiple angiogenic pathways by Dll4 and Notch in human umbilical vein endothelial cells. Harrington LS, Sainson RC, Williams CK, Taylor JM, Shi W, Li JL, et al. Microvasc Res 2008 75 144 154 (Pubitemid 351249857)
27. The VEGF receptor Flt-1 spatially modulates Flk-1 signaling and blood vessel branching. Kappas NC, Zeng G, Chappell JC, Kearney JB, Hazarika S, Kallianos KG, et al. J Cell Biol 2008 181 847 858 (Pubitemid 351786988)
28. The VEGF receptor flt-1 (VEGFR-1) is a positive modulator of vascular sprout formation and branching morphogenesis. Kearney JB, Kappas NC, Ellerstrom C, DiPaola FW, Bautch VL, Blood 2004 103 4527 4535 (Pubitemid 38745980)
29. Endothelial cells dynamically compete for the tip cell position during angiogenic sprouting. Jakobsson L, Franco CA, Bentley K, Collins RT, Ponsioen B, Aspalter IM, et al. Nat Cell Biol 2010 12 943 953
30. DLL4 blockade inhibits tumor growth and reduces tumor-initiating cell frequency. Hoey T, Yen WC, Axelrod F, Basi J, Donigian L, Dylla S, et al. Cell Stem Cell 2009 5 168 177
31. Inhibition of delta-like-4-mediated signaling impairs reparative angiogenesis after ischemia. Al Haj ZA, Oikawa A, Bazan-Peregrino M, Meloni M, Emanueli C, Madeddu P, Circ Res 2010 107 283 293
32. The many facets of Notch ligands. D'Souza B, Miyamoto A, Weinmaster G, Oncogene 2008 27 5148 5167
33. Fringe glycosyltransferases differentially modulate Notch1 proteolysis induced by Delta1 and Jagged1. Yang LT, Nichols JT, Yao C, Manilay JO, Robey EA, Weinmaster G, Mol Biol Cell 2005 16 927 942 (Pubitemid 40173985)
34. The notch ligands Dll4 and Jagged1 have opposing effects on angiogenesis. Benedito R, Roca C, Sorensen I, Adams S, Gossler A, Fruttiger M, et al. Cell 2009 137 1124 1135
35. TNF primes endothelial cells for angiogenic sprouting by inducing a tip cell phenotype. Sainson RC, Johnston DA, Chu HC, Holderfield MT, Nakatsu MN, Crampton SP, et al. Blood 2008 111 4997 5007
36. VEGFR-3 in adult angiogenesis. Witmer AN, van Blijswijk BC, Dai J, Hofman P, Partanen TA, Vrensen GF, et al. J Pathol 2001 195 490 497 (Pubitemid 33069675)
37. Cardiovascular failure in mouse embryos deficient in VEGF receptor-3. Dumont DJ, Jussila L, Taipale J, Lymboussaki A, Mustonen T, Pajusola K, et al. Science 1998 282 946 949 (Pubitemid 28507528)
38. VEGFR-3 and its ligand VEGF-C are associated with angiogenesis in breast cancer. Valtola R, Salven P, Heikkila P, Taipale J, Joensuu H, Rehn M, et al. Am J Pathol 1999 154 1381 1390 (Pubitemid 29226433)
39. Notch alters VEGF responsiveness in human and murine endothelial cells by direct regulation of VEGFR-3 expression. Shawber CJ, Funahashi Y, Francisco E, Vorontchikhina M, Kitamura Y, Stowell SA, et al. J Clin Invest 2007 117 3369 3382 (Pubitemid 350096993)
40. Role of endothelial progenitors and other bone marrow-derived cells in the development of the tumor vasculature. Ahn GO, Brown JM, Angiogenesis 2009 12 159 164
41. Specific Jagged-1 signal from bone marrow microenvironment is required for endothelial progenitor cell development for neovascularization. Kwon SM, Eguchi M, Wada M, Iwami Y, Hozumi K, Iwaguro H, et al. Circulation 2008 118 157 165
42. Homing to hypoxia: HIF-1 as a mediator of progenitor cell recruitment to injured tissue. Ceradini DJ, Gurtner GC, Trends Cardiovasc Med 2005 15 57 63 (Pubitemid 40693388)
43. Notch-RBP-J signaling regulates the mobilization and function of endothelial progenitor cells by dynamic modulation of CXCR4 expression in mice. Wang L, Wang YC, Hu XB, Zhang BF, Dou GR, He F, et al. PLoS One 2009 4 7572
44. Simvastatin enhances bone marrow stromal cell differentiation into endothelial cells via notch signaling pathway. Xu J, Liu X, Chen J, Zacharek A, Cui X, Savant-Bhonsale S, et al. Am J Physiol Cell Physiol 2009 296 535 C543
45. Inflammation dysregulates Notch signaling in endothelial cells: implication of Notch2 and Notch4 to endothelial dysfunction. Quillard T, Devalliere J, Coupel S, Charreau B, Biochem Pharmacol 2010 80 2032 2041
46. Notch2 signaling sensitizes endothelial cells to apoptosis by negatively regulating the key protective molecule survivin. Quillard T, Devalliere J, Chatelais M, Coulon F, Seveno C, Romagnoli M, et al. PLoS One 2009 4 8244
47. Notch4 inhibits endothelial apoptosis via RBP-Jkappa-dependent and -independent pathways. MacKenzie F, Duriez P, Wong F, Noseda M, Karsan A, J Biol Chem 2004 279 11657 11663 (Pubitemid 38401668)
48. Microvascular retinal endothelial and pericyte cell apoptosis in vitro: role of Hedgehog and Notch signaling. Walshe TE, Connell P, Cryan L, Ferguson G, Gardiner T, Morrow D, et al. Invest Ophthalmol Vis Sci 2011 52 4472 83
49. Critical role of endothelial Notch1 signaling in postnatal angiogenesis. Takeshita K, Satoh M, Ii M, Silver M, Limbourg FP, Mukai Y, et al. Circ Res 2007 100 70 78 (Pubitemid 46066775)
50. Targeting Notch to target cancer stem cells. Pannuti A, Foreman K, Rizzo P, Osipo C, Golde T, Osborne B, et al. Clin Cancer Res 2010 16 3141 3152
51. Mammary stem cells and breast cancer-role of Notch signalling. Farnie G, Clarke RB, Stem Cell Rev 2007 3 169 175 (Pubitemid 350129719)
52. Novel cell culture technique for primary ductal carcinoma in situ: role of Notch and epidermal growth factor receptor signaling pathways. Farnie G, Clarke RB, Spence K, Pinnock N, Brennan K, Anderson NG, et al. J Natl Cancer Inst 2007 99 616 627 (Pubitemid 47073543)
53. p66Shc/Notch-3 interplay controls self-renewal and hypoxia survival in human stem/progenitor cells of the mammary gland expanded in vitro as mammospheres. Sansone P, Storci G, Giovannini C, Pandolfi S, Pianetti S, Taffurelli M, et al. Stem Cells 2007 25 807 815 (Pubitemid 46354241)
54. Cancer stem cells: implications for cancer treatment and prevention. Kakarala M, Wicha MS, Cancer J 2007 13 271 275
55. Selective targeting of cancer stem cells: a new concept in cancer therapeutics. Korkaya H, Wicha MS, BioDrugs 2007 21 299 310 (Pubitemid 47529469)
56. Notch pathway inhibition depletes stem-like cells and blocks engraftment in embryonal brain tumors. Fan X, Matsui W, Khaki L, Stearns D, Chun J, Li YM, et al. Cancer Res 2006 66 7445 7452 (Pubitemid 44289197)
57. Notch pathway blockade depletes cd133-positive glioblastoma cells and inhibits growth of tumor neurospheres and xenografts. Fan X, Khaki L, Zhu TS, Soules ME, Talsma CE, Gul N, et al. Stem Cells 2010 28 5 16
58. Notch promotes radioresistance of glioma stem cells. Wang J, Wakeman TP, Lathia JD, Hjelmeland AB, Wang XF, White RR, et al. Stem Cells 2010 28 17 28
59. Regulation of breast cancer stem cell activity by signaling through the Notch4 receptor. Harrison H, Farnie G, Howell SJ, Rock RE, Stylianou S, Brennan KR, et al. Cancer Res 2010 70 709 718
60. Breast cancer stem cells: something out of notching? Harrison H, Farnie G, Brennan KR, Clarke RB, Cancer Res 2010 70 8973 8976
61. Role of Notch signaling in cell-fate determination of human mammary stem/progenitor cells. Dontu G, Jackson KW, McNicholas E, Kawamura MJ, Abdallah WM, Wicha MS, Breast Cancer Res 2004 6 605 R615
62. Transcriptome analysis of the normal human mammary cell commitment and differentiation process. Raouf A, Zhao Y, To K, Stingl J, Delaney A, Barbara M, et al. Cell Stem Cell 2008 3 109 118
63. Inhibition of Notch signaling reduces the stem-like population of breast cancer cells and prevents mammosphere formation. Grudzien P, Lo S, Albain KS, Robinson P, Rajan P, Strack PR, et al. Anticancer Res 2010 30 3853 3867
64. Targeting both Notch and ErbB-2 signalling pathways is required for prevention of ErbB-2-positive breast tumour recurrence. Pandya K, Meeke K, Clementz AG, Rogowski A, Roberts J, Miele L, et al. Br J Cancer 2011 105 796 806
65. Inhibition of notch signaling in glioblastoma targets cancer stem cells via an endothelial cell intermediate. Hovinga KE, Shimizu F, Wang R, Panagiotakos G, Van Der Heijden M, Moayedpardazi H, et al. Stem Cells 2010 28 1019 1029
66. Stem cell-like glioma cells promote tumor angiogenesis through vascular endothelial growth factor. Bao S, Wu Q, Sathornsumetee S, Hao Y, Li Z, Hjelmeland AB, et al. Cancer Res 2006 66 7843 7848 (Pubitemid 44299144)
67. A perivascular niche for brain tumor stem cells. Calabrese C, Poppleton H, Kocak M, Hogg TL, Fuller C, Hamner B, et al. Cancer Cell 2007 11 69 82 (Pubitemid 46054518)
68. Glioma tumor stem-like cells promote tumor angiogenesis and vasculogenesis via vascular endothelial growth factor and stromal-derived factor 1. Folkins C, Shaked Y, Man S, Tang T, Lee CR, Zhu Z, et al. Cancer Res 2009 69 7243 7251
69. Making a tumour's bed: glioblastoma stem cells and the vascular niche. Gilbertson RJ, Rich JN, Nat Rev Cancer 2007 7 733 736 (Pubitemid 47463683)
70. A hypoxic niche regulates glioblastoma stem cells through hypoxia inducible factor 2 alpha. Seidel S, Garvalov BK, Wirta V, von Stechow L, Schanzer A, Meletis K, et al. Brain 2010 133 983 995
71. Hypoxia requires notch signaling to maintain the undifferentiated cell state. Gustafsson MV, Zheng X, Pereira T, Gradin K, Jin S, Lundkvist J, et al. Dev Cell 2005 9 617 628 (Pubitemid 41555144)
72. Oxygen concentration determines the biological effects of NOTCH-1 signaling in adenocarcinoma of the lung. Chen Y, De Marco MA, Graziani I, Gazdar AF, Strack PR, Miele L, et al. Cancer Res 2007 67 7954 7959 (Pubitemid 47395124)
73. Notch-1 stimulates survival of lung adenocarcinoma cells during hypoxia by activating the IGF-1R pathway. Eliasz S, Liang S, Chen Y, De Marco MA, Machek O, Skucha S, et al. Oncogene 2010 29 2488 2498
74. Notch signaling mediates hypoxia-induced tumor cell migration and invasion. Sahlgren C, Gustafsson MV, Jin S, Poellinger L, Lendahl U, Proc Natl Acad Sci USA 2008 105 6392 6397 (Pubitemid 351758356)
75. Transendothelial function of human metastatic melanoma cells: role of the microenvironment in cell-fate determination. Hendrix MJ, Seftor RE, Seftor EA, Gruman LM, Lee LM, Nickoloff BJ, et al. Cancer Res 2002 62 665 668 (Pubitemid 34126938)
76. Vasculogenic mimicry and tumour-cell plasticity: lessons from melanoma. Hendrix MJ, Seftor EA, Hess AR, Seftor RE, Nat Rev Cancer 2003 3 411 421 (Pubitemid 37328845)
77. Tumour vascularization via endothelial differentiation of glioblastoma stem-like cells. Ricci-Vitiani L, Pallini R, Biffoni M, Todaro M, Invernici G, Cenci T, et al. Nature 2010 468 824 828
78. Tumor-infiltrating CD4+ Th17 cells produce IL-17 in tumor microenvironment and promote tumor progression in human gastric cancer. Iida T, Iwahashi M, Katsuda M, Ishida K, Nakamori M, Nakamura M, et al. Oncol Rep 2011 25 1271 1277
79. Th17 cells: positive or negative role in tumor? Ji Y, Zhang W, Cancer Immunol Immunother 2010 59 979 987
80. Human Th17 cells can be induced through head and neck cancer and have a functional impact on HNSCC development. Kesselring R, Thiel A, Pries R, Trenkle T, Wollenberg B, Br J Cancer 2010 103 1245 1254
81. Human endothelial cells generate Th17 and regulatory T cells under inflammatory conditions. Taflin C, Favier B, Baudhuin J, Savenay A, Hemon P, Bensussan A, et al. Proc Natl Acad Sci USA 2011 108 2891 2896
82. Interleukin-17 enhances bFGF-, HGF- and VEGF-induced growth of vascular endothelial cells. Takahashi H, Numasaki M, Lotze MT, Sasaki H, Immunol Lett 2005 98 189 193 (Pubitemid 40602629)
83. Interleukin-17 promotes angiogenesis and tumor growth. Numasaki M, Fukushi J, Ono M, Narula SK, Zavodny PJ, Kudo T, et al. Blood 2003 101 2620 2627 (Pubitemid 36857622)
84. IL-17 expression by breast-cancer-associated macrophages: IL-17 promotes invasiveness of breast cancer cell lines. Zhu X, Mulcahy LA, Mohammed RA, Lee AH, Franks HA, Kilpatrick L, et al. Breast Cancer Res 2008 10 95
85. IL-17 secreted by tumor reactive T cells induces IL-8 release by human renal cancer cells. Inozume T, Hanada K, Wang QJ, Yang JC, J Immunother 2009 32 109 117
86. High tumor levels of IL6 and IL8 abrogate preclinical efficacy of the gamma-secretase inhibitor, RO4929097. He W, Luistro L, Carvajal D, Smith M, Nevins T, Yin X, et al. Mol Oncol 2011 5 292 301
87. Preclinical profile of a potent gamma-secretase inhibitor targeting notch signaling with in vivo efficacy and pharmacodynamic properties. Luistro L, He W, Smith M, Packman K, Vilenchik M, Carvajal D, et al. Cancer Res 2009 69 7672 7680
88. Over-expression of the NOTCH Ligand JAG2 in Malignant Plasma Cells from Multiple Myeloma Patients and Cell Lines. Houde C, Li Y, Song L, Barton K, Zhang Q, Godwin J, et al. Blood 2004 104 3697 3704 (Pubitemid 39564447)
89. Inhibitors of gamma-secretase block in vivo and in vitro T helper type 1 polarization by preventing Notch upregulation of Tbx21. Minter LM, Turley DM, Das P, Shin HM, Joshi I, Lawlor RG, et al. Nat Immunol 2005 6 680 688 (Pubitemid 41716741)
90. Notch signaling regulates mouse and human Th17 differentiation. Keerthivasan S, Suleiman R, Lawlor RG, Roderick J, Bates T, Minter LM, et al. J Immunol 2011 187 692 701
91. Tumor-associated macrophages regulate tumorigenicity and anticancer drug responses of cancer stem/initiating cells. Jinushi M, Chiba S, Yoshiyama H, Masutomi K, Kinoshita I, Dosaka-Akita H, et al. Proc Natl Acad Sci USA 2011 108 12425 12430
92. VEGFR-3 controls tip to stalk conversion at vessel fusion sites by reinforcing Notch signalling. Tammela T, Zarkada G, Nurmi H, Jakobsson L, Heinolainen K, Tvorogov D, et al. Nat Cell Biol 2011 13 1202 1213
93. Cancer-associated-fibroblasts and tumour cells: a diabolic liaison driving cancer progression. Cirri P, Chiarugi P, Cancer Metastasis Rev 2011
94. Targeting cancer stem cells by inhibiting Wnt, Notch, and Hedgehog pathways. Takebe N, Harris PJ, Warren RQ, Ivy SP, Nat Rev Clin Oncol 2011 8 97 106
95. Modulation of cancer stem cell biomarkers by the notch inhibitor MK0752 added to endocrine therapy for early stage ER+ breast cancer. Albain K, Czerlanis C, Zlobin A, Covington KR, Rajan P, Godellas C, et al. Cancer Res 2011 71 24 Suppl 97s
96. Promoting angiogenesis via manipulation of VEGF responsiveness with notch signaling. Cao L, Arany PR, Wang YS, Mooney DJ, Biomaterials 2009 30 4085 4093
97. Vascular endothelial growth factor mediates intracrine survival in human breast carcinoma cells through internally expressed VEGFR1/FLT1. Lee TH, Seng S, Sekine M, Hinton C, Fu Y, Avraham HK, et al. PLoS Med 2007 4 186
98. Expression of vascular permeability factor (vascular endothelial growth factor) and its receptors in breast cancer. Brown LF, Berse B, Jackman RW, Tognazzi K, Guidi AJ, Dvorak HF, et al. Hum Pathol 1995 26 86 91
99. Oral administration of pyrrolidine dithiocarbamate (PDTC) inhibits VEGF expression, tumor angiogenesis and growth of breast cancer in female mice. Gu JW, Young E, Busby B, Covington J, Tan W, Johnson JW, Cancer Biol Ther 2009 8 514 521
100. SU11248, a selective tyrosine kinases inhibitor suppresses breast tumor angiogenesis and growth via targeting both tumor vasculature and breast cancer cells. Young E, Miele L, Tucker KB, Huang M, Wells J, Gu JW, Cancer Biol Ther 2010 10 703 711
101. The adaptor-associated kinase 1, AAK1, is a positive regulator of the Notch pathway. Gupta-Rossi N, Ortica S, Meas-Yedid V, Heuss S, Moretti J, Olivo-Marin JC, et al. J Biol Chem 2011 286 18720 18730